Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q2

3034.TEDINET S100SA13
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥88.5bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥82.5bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥3.6bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥4.0bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥3.7bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.2bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥3.6bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥4.2bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥1.9bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥2.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥107.4bnat 2023-09-30Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥91.0bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥57.1bnat 2023-09-30Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥50.3bnat 2023-09-30Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥45.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥17.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥17.3bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥14.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥16.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥6.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥11.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥4.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥9.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥2.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥2.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥50.82023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.582023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥64.112022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.922022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio46.8%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio50.4%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥231m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥231m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.8bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-09-30¥81.0bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-09-30¥81.0bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥63m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.7bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-09-30¥7.7bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-09-30¥7.6bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥167m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-09-30¥658m
—segment totalrevenue2023-04-01 → 2023-09-30¥88.8bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥88.5bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥231m
—segment totalsegment profit2023-04-01 → 2023-09-30¥5.4bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥181m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥1.7bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-09-30¥75.6bn
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥58m
jpcrp040300-q2r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.1bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥7.0bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.9bn
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥123m
jpcrp040300-q2r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥645m
—segment totalrevenue2022-04-01 → 2022-09-30¥82.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥82.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥181m
—segment totalsegment profit2022-04-01 → 2022-09-30¥5.7bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 510
ItemContextValueUnit
Gross profitPrior1YTDDuration10856000000JPY
Gross profitCurrentYTDDuration11031000000JPY
Selling general and administrative expensesPrior1YTDDuration6834000000JPY
Selling general and administrative expensesCurrentYTDDuration7472000000JPY
Operating incomePrior1YTDDuration4022000000JPY
Operating incomeCurrentYTDDuration3559000000JPY
House rent income noiPrior1YTDDuration24000000JPY
House rent income noiCurrentYTDDuration62000000JPY
Commission fee noiPrior1YTDDuration52000000JPY
Commission fee noiCurrentYTDDuration73000000JPY
Insurance premiums refunded cancellation noiPrior1YTDDuration－JPY
Insurance premiums refunded cancellation noiCurrentYTDDuration1000000JPY
Subsidy income noiPrior1YTDDuration3000000JPY
Subsidy income noiCurrentYTDDuration4000000JPY
Guarantee commission received noiPrior1YTDDuration29000000JPY
Guarantee commission received noiCurrentYTDDuration29000000JPY
Subsidy income noi bountyPrior1YTDDuration86000000JPY
Subsidy income noi bountyCurrentYTDDuration21000000JPY
Other noiPrior1YTDDuration50000000JPY
Other noiCurrentYTDDuration41000000JPY
Non operating incomePrior1YTDDuration246000000JPY
Non operating incomeCurrentYTDDuration235000000JPY
Interest expenses noePrior1YTDDuration39000000JPY
Interest expenses noeCurrentYTDDuration51000000JPY
Rent expenses noePrior1YTDDuration21000000JPY
Rent expenses noeCurrentYTDDuration34000000JPY
Other noePrior1YTDDuration34000000JPY
Other noeCurrentYTDDuration32000000JPY
Non operating expensesPrior1YTDDuration94000000JPY
Non operating expensesCurrentYTDDuration118000000JPY
Ordinary incomePrior1YTDDuration4174000000JPY
Ordinary incomeCurrentYTDDuration3675000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration0JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration1000000JPY
Extraordinary incomePrior1YTDDuration0JPY
Extraordinary incomeCurrentYTDDuration1000000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration14000000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration14000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration3000000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration10000000JPY
Loss on withdrawal from employees pension fund elPrior1YTDDuration－JPY
Loss on withdrawal from employees pension fund elCurrentYTDDuration38000000JPY
Other elPrior1YTDDuration－JPY
Other elCurrentYTDDuration1000000JPY
Extraordinary lossPrior1YTDDuration18000000JPY
Extraordinary lossCurrentYTDDuration64000000JPY
Income before income taxesPrior1YTDDuration4156000000JPY
Income before income taxesCurrentYTDDuration3612000000JPY
Income taxesPrior1YTDDuration1792000000JPY
Income taxesCurrentYTDDuration1731000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass